Sentry Petroleum Ltd
Sentry Petroleum Ltd
Your view on SPLM
Overview
What the company does, where it operates, and who runs it.
About Sentry Petroleum Ltd
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Sage Ellie
- Headquarters
- 999 18th Street, Denver, CO, US
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Sage Ellie
- Headquarters
- 999 18th Street, Denver, CO, US
Sentry Petroleum Ltd., an exploration stage company, acquires, explores, and develops oil and gas properties. It holds 100% interests in 4 exploration permits, including ATP 862, 864, 865, and 866 covering an area of approximately 6.9 million net acres located in the Adavale Basin, Queensland.
The company was formerly known as Summit Exploration Inc. and changed its name to Sentry Petroleum Ltd. in December 2007. Sentry Petroleum Ltd. was founded in 2006 and is based in Denver, Colorado.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Sentry Petroleum Ltd, and the rating behind it. SPLM last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Sentry Petroleum Ltd. Starting points for Sentry Petroleum Ltd: beta 20.58 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Sentry Petroleum Ltd. Sentry Petroleum Ltd does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Sentry Petroleum Ltd. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Sentry Petroleum Ltd. Sentry Petroleum Ltd has reported as a listed company since 2007. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Sentry Petroleum Ltd valued side by side against its closest peers. Sentry Petroleum Ltd is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Sentry Petroleum Ltd, and how their positions are changing. At a $4,745 market value, institutional positions materially move Sentry Petroleum Ltd's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Sentry Petroleum Ltd executives and directors. Shares of Sentry Petroleum Ltd have traded between $0.0001 and $0.0001 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Sentry Petroleum Ltd. Sentry Petroleum Ltd is a $4,745 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Sentry Petroleum Ltd. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Sentry Petroleum Ltd. Coverage tracks Sentry Petroleum Ltd within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.